Annual FCF
-$268.02 M
+$12.12 M+4.33%
31 December 2023
Summary:
Pacific Biosciences of California annual free cash flow is currently -$268.02 million, with the most recent change of +$12.12 million (+4.33%) on 31 December 2023. During the last 3 years, it has fallen by -$286.48 million (-1551.56%). PACB annual FCF is now -1551.56% below its all-time high of $18.46 million, reached on 31 December 2020.PACB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$44.68 M
+$11.07 M+19.85%
30 September 2024
Summary:
Pacific Biosciences of California quarterly free cash flow is currently -$44.68 million, with the most recent change of +$11.07 million (+19.85%) on 30 September 2024. Over the past year, it has increased by +$21.34 million (+32.32%). PACB quarterly FCF is now -159.37% below its all-time high of $75.25 million, reached on 31 March 2020.PACB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$239.56 M
+$21.34 M+8.18%
30 September 2024
Summary:
Pacific Biosciences of California TTM free cash flow is currently -$239.56 million, with the most recent change of +$21.34 million (+8.18%) on 30 September 2024. Over the past year, it has increased by +$34.52 million (+12.59%). PACB TTM FCF is now -1259.33% below its all-time high of $20.66 million, reached on 31 March 2020.PACB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.3% | +32.3% | +12.6% |
| 3 y3 years | -1551.6% | -6.9% | -147.3% |
| 5 y5 years | -292.5% | -147.0% | -192.6% |
PACB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1551.6% | +4.3% | -29.3% | +54.6% | -147.3% | +19.0% |
| 5 y | 5 years | -1551.6% | +4.3% | -159.4% | +54.6% | -1259.3% | +19.0% |
| alltime | all time | -1551.6% | +4.3% | -159.4% | +54.6% | -1259.3% | +19.0% |
Pacific Biosciences Of California Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$44.68 M(-19.9%) | -$239.56 M(-8.2%) |
| June 2024 | - | -$55.74 M(-29.9%) | -$260.90 M(+4.7%) |
| Mar 2024 | - | -$79.56 M(+33.5%) | -$249.16 M(-7.0%) |
| Dec 2023 | -$268.02 M(-4.3%) | -$59.58 M(-9.7%) | -$268.02 M(-2.2%) |
| Sept 2023 | - | -$66.01 M(+50.0%) | -$274.08 M(-0.4%) |
| June 2023 | - | -$44.01 M(-55.3%) | -$275.31 M(-7.0%) |
| Mar 2023 | - | -$98.41 M(+49.9%) | -$295.88 M(+5.6%) |
| Dec 2022 | -$280.14 M(+139.2%) | -$65.65 M(-2.4%) | -$280.14 M(+12.5%) |
| Sept 2022 | - | -$67.24 M(+4.1%) | -$249.04 M(+11.4%) |
| June 2022 | - | -$64.58 M(-21.9%) | -$223.57 M(+26.8%) |
| Mar 2022 | - | -$82.67 M(+139.3%) | -$176.27 M(+50.5%) |
| Dec 2021 | -$117.11 M(-734.3%) | -$34.55 M(-17.3%) | -$117.11 M(+20.9%) |
| Sept 2021 | - | -$41.77 M(+141.7%) | -$96.89 M(+31.9%) |
| June 2021 | - | -$17.28 M(-26.5%) | -$73.46 M(-8.5%) |
| Mar 2021 | - | -$23.50 M(+64.0%) | -$80.29 M(-534.8%) |
| Dec 2020 | $18.46 M(-122.8%) | -$14.33 M(-21.9%) | $18.46 M(+27.6%) |
| Sept 2020 | - | -$18.34 M(-23.9%) | $14.47 M(-1.7%) |
| June 2020 | - | -$24.11 M(-132.0%) | $14.73 M(-28.7%) |
| Mar 2020 | - | $75.25 M(-510.7%) | $20.66 M(-125.5%) |
| Dec 2019 | -$81.15 M(+18.8%) | -$18.32 M(+1.3%) | -$81.15 M(-0.9%) |
| Sept 2019 | - | -$18.09 M(-0.5%) | -$81.87 M(+4.9%) |
| June 2019 | - | -$18.17 M(-31.6%) | -$78.05 M(+3.1%) |
| Mar 2019 | - | -$26.57 M(+39.5%) | -$75.73 M(+10.9%) |
| Dec 2018 | -$68.28 M(-12.4%) | -$19.04 M(+33.4%) | -$68.28 M(-3.1%) |
| Sept 2018 | - | -$14.27 M(-10.0%) | -$70.50 M(-8.8%) |
| June 2018 | - | -$15.85 M(-17.1%) | -$77.33 M(-0.5%) |
| Mar 2018 | - | -$19.12 M(-10.1%) | -$77.73 M(-0.3%) |
| Dec 2017 | -$77.95 M(+2.4%) | -$21.26 M(+0.8%) | -$77.95 M(+7.9%) |
| Sept 2017 | - | -$21.09 M(+29.8%) | -$72.24 M(+4.2%) |
| June 2017 | - | -$16.26 M(-15.9%) | -$69.33 M(-7.3%) |
| Mar 2017 | - | -$19.34 M(+24.4%) | -$74.75 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$76.14 M(+49.6%) | -$15.55 M(-14.4%) | -$76.14 M(+22.5%) |
| Sept 2016 | - | -$18.18 M(-16.2%) | -$62.18 M(+3.2%) |
| June 2016 | - | -$21.68 M(+4.6%) | -$60.23 M(+28.2%) |
| Mar 2016 | - | -$20.72 M(+1201.8%) | -$46.99 M(-7.7%) |
| Dec 2015 | -$50.90 M(-4.1%) | -$1.59 M(-90.2%) | -$50.90 M(-21.9%) |
| Sept 2015 | - | -$16.23 M(+92.1%) | -$65.14 M(+17.7%) |
| June 2015 | - | -$8.45 M(-65.7%) | -$55.34 M(-9.2%) |
| Mar 2015 | - | -$24.63 M(+55.5%) | -$60.97 M(+14.9%) |
| Dec 2014 | -$53.08 M(+72.7%) | -$15.83 M(+146.4%) | -$53.08 M(+2.2%) |
| Sept 2014 | - | -$6.42 M(-54.4%) | -$51.92 M(+92.3%) |
| June 2014 | - | -$14.09 M(-15.8%) | -$27.00 M(-8.8%) |
| Mar 2014 | - | -$16.73 M(+14.0%) | -$29.60 M(-3.7%) |
| Dec 2013 | -$30.74 M(-60.9%) | -$14.68 M(-179.4%) | -$30.74 M(-11.5%) |
| Sept 2013 | - | $18.49 M(-210.8%) | -$34.73 M(-51.3%) |
| June 2013 | - | -$16.69 M(-6.6%) | -$71.35 M(-9.4%) |
| Mar 2013 | - | -$17.87 M(-4.2%) | -$78.78 M(+0.3%) |
| Dec 2012 | -$78.53 M(-30.0%) | -$18.66 M(+2.9%) | -$78.53 M(+3.2%) |
| Sept 2012 | - | -$18.13 M(-24.8%) | -$76.07 M(-9.5%) |
| June 2012 | - | -$24.12 M(+36.9%) | -$84.05 M(-11.4%) |
| Mar 2012 | - | -$17.61 M(+8.6%) | -$94.92 M(-15.4%) |
| Dec 2011 | -$112.26 M(-11.8%) | -$16.21 M(-37.9%) | -$112.26 M(-17.7%) |
| Sept 2011 | - | -$26.11 M(-25.4%) | -$136.32 M(-5.7%) |
| June 2011 | - | -$34.98 M(+0.1%) | -$144.61 M(+7.8%) |
| Mar 2011 | - | -$34.95 M(-13.2%) | -$134.18 M(+5.4%) |
| Dec 2010 | -$127.25 M(+59.0%) | -$40.28 M(+17.1%) | -$127.25 M(+46.3%) |
| Sept 2010 | - | -$34.39 M(+40.1%) | -$86.98 M(+65.4%) |
| June 2010 | - | -$24.55 M(-12.4%) | -$52.59 M(+87.6%) |
| Mar 2010 | - | -$28.03 M | -$28.03 M |
| Dec 2009 | -$80.02 M(+81.8%) | - | - |
| Dec 2008 | -$44.01 M(+122.5%) | - | - |
| Dec 2007 | -$19.78 M | - | - |
FAQ
- What is Pacific Biosciences of California annual free cash flow?
- What is the all time high annual FCF for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual FCF year-on-year change?
- What is Pacific Biosciences of California quarterly free cash flow?
- What is the all time high quarterly FCF for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly FCF year-on-year change?
- What is Pacific Biosciences of California TTM free cash flow?
- What is the all time high TTM FCF for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM FCF year-on-year change?
What is Pacific Biosciences of California annual free cash flow?
The current annual FCF of PACB is -$268.02 M
What is the all time high annual FCF for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual free cash flow is $18.46 M
What is Pacific Biosciences of California annual FCF year-on-year change?
Over the past year, PACB annual free cash flow has changed by +$12.12 M (+4.33%)
What is Pacific Biosciences of California quarterly free cash flow?
The current quarterly FCF of PACB is -$44.68 M
What is the all time high quarterly FCF for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly free cash flow is $75.25 M
What is Pacific Biosciences of California quarterly FCF year-on-year change?
Over the past year, PACB quarterly free cash flow has changed by +$21.34 M (+32.32%)
What is Pacific Biosciences of California TTM free cash flow?
The current TTM FCF of PACB is -$239.56 M
What is the all time high TTM FCF for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM free cash flow is $20.66 M
What is Pacific Biosciences of California TTM FCF year-on-year change?
Over the past year, PACB TTM free cash flow has changed by +$34.52 M (+12.59%)